Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Cancer Treatment Reviews|April 6, 2013
mTOR inhibitors in advanced breast cancer: ready for prime time?Lesley-Ann Martin, Fabrice André, Mario Campone, et al.
Endocrine-Related Cancer|August 23, 2005
Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivationLesley-Ann Martin, Ian Farmer, Stephen R D Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancerGiles Davies, Janine Salter, Margaret Hills, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 6, 2005
Aromatase inhibitors: combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistanceStephen R D Johnston, Lesley-Ann Martin, Julia Head, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 13, 2007
Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancerStephen R D Johnston, Lesley-Ann Martin, Alex Leary, et al.
Molecular & Cellular Proteomics : MCP|December 20, 2023
Exploring the Spatial Landscape of the Estrogen Receptor Proximal Proteome With Antibody-Based Proximity LabelingCamilla Rega, Zuzanna Kozik, Lu Yu, et al.
Cancer|December 12, 2007
Enhancing endocrine response with novel targeted therapies: why have the clinical trials to date failed to deliver on the preclinical promise?Stephen R D Johnston, Alexandra Leary, Lesley-Ann Martin, et al.
Breast Cancer Research : BCR|May 22, 2012
Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancerMarion T Weigel, Zara Ghazoui, Anita Dunbier, et al.
The Journal of Biological Chemistry|May 31, 2003
Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivationLesley-Ann Martin, Ian Farmer, Stephen R D Johnston, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 4, 2002
Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivationChristina M W Chan, Lesley-Ann Martin, Stephen R D Johnston, et al.
Pageof 8